Endorphins

History

Opioid peptides in the brain were first discovered in 1973 by investigators at the University of Aberdeen, John Hughes and Hans Kosterlitz. They isolated "enkephalins" (from the Greek εγκέφαλος) from pig brain, identified as Met-enkephalin and Leu-enkephalin. This came after the discovery of a receptor that was proposed to produce the pain-relieving analgesic effects of morphine and other opioids, which led Kosterlitz and Hughes to their discovery of the endogenous opioid ligands. Research during this time was focused on the search for a painkiller that did not have the addictive character or overdose risk of morphine.

Rabi Simantov and Solomon H. Snyder isolated morphine-like peptides from calf brain. Eric J. Simon, who independently discovered opioid receptors, later termed these peptides as endorphins. This term was essentially assigned to any peptide that demonstrated morphine-like activity. In 1976, Choh Hao Li and David Chung recorded the sequences of α-, β-, and γ-endorphin isolated from camel pituitary glands for their opioid activity. Li determined that β-endorphin produced strong analgesic effects. Wilhelm Feldberg and Derek George Smyth in 1977 confirmed this, finding β-endorphin to be more potent than morphine. They also confirmed that its effects were reversed by naloxone, an opioid antagonist.

Studies have subsequently distinguished between enkephalins, endorphins, and endogenously produced true morphine, which is not a peptide. Opioid peptides are classified based on their precursor propeptide: all endorphins are synthesized from the precursor proopiomelanocortin (POMC), encoded by proenkephalin A, and dynorphins encoded by pre-dynorphin.

Etymology

The word endorphin is derived from ἔνδον / meaning "within" (endogenous, ἐνδογενής / , "proceeding from within"), and morphine, from Morpheus (), the god of dreams in the Greek mythology. Thus, endorphin is a contraction of 'endo(genous) (mo)rphin' (morphin being the old spelling of morphine).

Types

The class of endorphins consists of three endogenous opioid peptides: α-Endorphin, β-endorphin, and γ-endorphin. The endorphins are all synthesized from the precursor protein, proopiomelanocortin, and all contain a Met-enkephalin motif at their N-terminus: Tyr-Gly-Gly-Phe-Met. α-endorphin and γ-endorphin result from proteolytic cleavage of β-endorphin between the Thr(16)-Leu(17) residues and Leu(17)-Phe(18) respectively. α-endorphin has the shortest sequence, and β-endorphin has the longest sequence.

α-Endorphin and γ-endorphin are primarily found in the anterior and intermediate pituitary. While β-endorphin is studied for its opioid activity, α-endorphin and γ-endorphin both lack affinity for opiate receptors and thus do not affect the body in the same way that β-endorphin does. Some studies have characterized α-endorphin activity as similar to that of psychostimulants and γ-endorphin activity to that of neuroleptics separately.

Synthesis

Endorphin precursors are primarily produced in the pituitary gland. All three types of endorphins are fragments of the precursor protein proopiomelanocortin (POMC). At the trans-Golgi network, POMC binds to a membrane-bound protein, carboxypeptidase E (CPE). CPE facilitates POMC transport into immature budding vesicles. In mammals, pro-peptide convertase 1 (PC1) cleaves POMC into adrenocorticotropin (ACTH) and beta-lipotropin (β-LPH). β-LPH, a pituitary hormone with little opiate activity, is then continually fragmented into different peptides, including α-endorphin, β-endorphin, and γ-endorphin. Peptide convertase 2 (PC2) is responsible for cleaving β-LPH into β-endorphin and γ-lipotropin. Formation of α-endorphin and γ-endorphin results from proteolytic cleavage of β-endorphin.

Regulation

Noradrenaline has been shown to increase endorphins production within inflammatory tissues, resulting in an analgesic effect; the stimulation of sympathetic nerves by electro-acupuncture is believed to be the cause of its analgesic effects.

Mechanism of action

Endorphins are released from the pituitary gland, typically in response to pain, and can act in both the central nervous system (CNS) and the peripheral nervous system (PNS). In the PNS, β-endorphin is the primary endorphin released from the pituitary gland. Endorphins inhibit transmission of pain signals by binding μ-receptors of peripheral nerves, which block their release of neurotransmitter substance P. The mechanism in the CNS is similar but works by blocking a different neurotransmitter: gamma-aminobutyric acid (GABA). In turn, inhibition of GABA increases the production and release of dopamine, a neurotransmitter associated with reward learning.

Functions

Endorphins play a major role in the body's inhibitory response to pain. Research has demonstrated that meditation by trained individuals can be used to trigger endorphin release. Laughter may also stimulate endorphin production and elevate one's pain threshold.

Endorphin production can be triggered by vigorous aerobic exercise. The release of β-endorphin has been postulated to contribute to the phenomenon known as "runner's high". However, experimental blockade of the mu opioid receptor has shown that endorphins are not strictly necessary for the development of exercise-induced euphoria. It has been suggested that other neurotransmitters, namely endocannabinoids, are more likely contributors. Endorphins may partially mediate exercise-induced analgesia.

References

References

1. (1515). "Endogenous morphine: up-to-date review 2011". Folia Biologica.
2. (15 March 2017). "μ receptor". International Union of Basic and Clinical Pharmacology.
3. (September 2004). "Endogenous formation of morphine in human cells". Proceedings of the National Academy of Sciences of the United States of America.
4. (December 2020). "Roles of β-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism". International Journal of Molecular Sciences.
5. (June 1984). "Release of beta endorphin and met-enkephalin during exercise in normal women: response to training". British Medical Journal.
6. (July 1997). "Beta-endorphin response to exercise. An update". Sports Medicine.
7. "Endorphins: What They Are and How to Boost Them".
8. (1 January 1998). "Role of endorphins discovered". Public Broadcasting System.
9. (December 1975). "Identification of two related pentapeptides from the brain with potent opiate agonist activity". Nature.
10. (2011). "The Opiate Receptors". Humana Press.
11. (January 2006). "75 years of opioid research: the exciting but vain quest for the Holy Grail". British Journal of Pharmacology.
12. (2018). "Neuroscience". Sunderland.
13. (July 1976). "Morphine-like peptides in mammalian brain: isolation, structure elucidation, and interactions with the opiate receptor". Proceedings of the National Academy of Sciences of the United States of America.
14. (September 1975). "Effect of the opiate antagonist naloxone on body temperature in rats". Life Sciences.
15. (2013). "Handbook of Biologically Active Peptides". Elsevier.
16. (April 1976). "Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands". Proceedings of the National Academy of Sciences of the United States of America.
17. (May 2016). "60 YEARS OF POMC: Lipotropin and beta-endorphin: a perspective". Journal of Molecular Endocrinology.
18. (August 1976). "beta-endorphin is a potent analgesic agent". Proceedings of the National Academy of Sciences of the United States of America.
19. (July 1977). "C-fragment of lipotropin--an endogenous potent analgesic peptide". British Journal of Pharmacology.
20. (September 2004). "Endogenous formation of morphine in human cells". Proceedings of the National Academy of Sciences of the United States of America.
21. (October 2006). "De novo biosynthesis of morphine in animal cells: an evidence-based model". Medical Science Monitor.
22. (2016-01-14). "Opioid Receptors". Annual Review of Medicine.
23. (February 2012). "Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphins". Future Medicinal Chemistry.
24. (January 1984). "Action of proteolytic enzymes on lipotropins and endorphins: biosynthesis, biotransformation and fate". Pharmacology & Therapeutics.
25. (1992). "The Human Hypothalamus in Health and Disease, Proceedings of the 17th International Summer School of Brain Research, held at the Auditorium of the University of Amsterdam".
26. (November 1976). "Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity". Proceedings of the National Academy of Sciences of the United States of America.
27. (2024). "StatPearls". StatPearls Publishing.
28. (January 1984). "Action of proteolytic enzymes on lipotropins and endorphins: biosynthesis, biotransformation and fate". Pharmacology & Therapeutics.
29. (March 2004). "Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain". Endocrinology.
30. (October 2013). "Posttranslational modifications of proopiomelanocortin in vertebrates and their biological significance". Frontiers in Endocrinology.
31. (March 2004). "Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain". Endocrinology.
32. (2004). "Secretory granule biogenesis and neuropeptide sorting to the regulated secretory pathway in neuroendocrine cells". Journal of Molecular Neuroscience.
33. (November 1979). "Endorphins: new gut peptides with a familiar face". Gastroenterology.
34. (October 1978). "Biosynthesis of beta-endorphin from beta-lipotropin and a larger molecular weight precursor in rat pars intermedia". Proceedings of the National Academy of Sciences of the United States of America.
35. (September 1976). "Opioid peptides endorphins in pituitary and brain". Science.
36. (July 2004). "Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue". The European Journal of Neuroscience.
37. (March 2010). "Understanding endorphins and their importance in pain management". Hawaii Medical Journal.
38. (November 2014). "Happiness & Health: The Biological Factors- Systematic Review Article". Iranian Journal of Public Health.
39. (March 2012). "Social laughter is correlated with an elevated pain threshold". Proceedings of the Royal Society B: Biological Sciences.
40. (November 2008). "The runner's high: opioidergic mechanisms in the human brain". Cerebral Cortex.
41. (2008-03-27). "Yes, Running Can Make You High". The New York Times.
42. "News: Getting to the Bottom of the Runner's... (The New York Times) - Behind the headlines - NLM".
43. (June 2023). "Do Endocannabinoids Cause the Runner's High? Evidence and Open Questions". The Neuroscientist.
44. (2013). "Effects of exercise and physical activity on anxiety". Frontiers in Psychiatry.